The future of clinical cancer genomics

Whether or not it was first said by atom-splitter Niels Bohr or splitter-ball catcher Yogi Berra, we all agree “it’s tough to make predictions- especially about the future.” In the concluding section of this monograph on the current status of predictive cancer genomics, it is appropriate to ponder the future of this translational field of medical science. As will also be addressed here, it is particula rly instructive for the providers and consumers of the rapid advances in genomics and medicine to make their own predictions of the impact of “personalized genomics” on preventive oncology.
Source: Seminars in Oncology - Category: Cancer & Oncology Authors: Source Type: research